US 7,413,754 B2
	Use of extracts of the genus Cimicifugaas organoselective medicines for treating diseases of the genitourinary system caused by sex hormones
Wolfgang Wuttke, Bovenden (Germany); Hubertus Jarry, Neu-Eichenberg (Germany); Volker Christoffel, Buchberg (Germany); and Barbara Spengler, Neumarkt (Germany)
Assigned to Bionorica AG, Neumarkt (Germany)
Appl. No. 10/490,190 PCT Filed Sep. 16, 2002, PCT No. PCT/EP02/10383 § 371(c)(1), (2), (4) Date Sep. 13, 2004, PCT Pub. No. WO03/024465, PCT Pub. Date Mar. 27, 2003.
Claims priority of application No. 101 46 159 (DE), filed on Sep. 19, 2001.
Prior Publication US 2005/0019437 A1, Jan. 27, 2005
Int. Cl. A61K 36/00 (2006.01)

U.S. Cl. 424—725

6 Claims

1. A method for alleviating a prostatic disorder selected from the group consisting of benign and malignant prostate hyperplasy comprising the step of administering an estrogen-type organoselective medicament to alleviate the prostatic disorder, the medicament comprising an extract from a Cimicifuga species.